MAPS Canada presents our Clinical Research Community of Practice! We’re bringing together professionals who are passionate about advancing access to psychedelic-assisted therapy in Canada in clinical research settings.
Join our Clinical Research CoP!
Our purpose is to cultivate a collaborative environment where clinicians, researchers, policy experts, and advocates can exchange best practices, discuss challenges, and align on quality, ethics, and protocols in clinical trial treatment pathways.
Clinical Research is a viable route to access
Clinical research is a safe and robust pathway to access psychedelic-assisted therapy in Canada legally—and they’re essential for future approval and system integration. Clinical trials pave the way for mainstream, regulated therapeutic use.
Who Should Participate:
- Professionals looking to learn more about clinical research as a route to treatment
- Researchers with experience in clinical trials who can share perspectives on treatment in research settings
- Advocates passionate about advancing access to psychedelic-assisted therapy
- Professionals looking to connect and foster peer support regarding psychedelic clinical trials in Canada
- Patients with lived experience
- Anyone else involved in psychedelic research
We hope that the community will be:
- A vibrant place to discuss what works and what doesn’t in conducting psychedelic studies, and to ask questions about related topics (e.g., protocol creation);
- A place to identify gaps in knowledge and practice, and to co-create resources to address them; and
- A one-stop “shop” for resources and expertise.
Sign up to become a Community of Practice member and join us for bi-monthly Zoom meetings to connect and collaborate! We will use this platform to discuss clinical trials as a treatment pathway, ongoing research, and barriers and ethics around Canadian psychedelic research.
Questions? Feel free to contact us at: research_cop@mapscanada.org